Skip to main content
Clinical Trials/NCT01362868
NCT01362868TerminatedNot Applicable

Water Drinking Test (WDT) During Continuous Recording of Intraocular Pressure Fluctuation

Sensimed AG2 sites in 1 country32 target enrollmentStarted: May 1, 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
32
Locations
2
Primary Endpoint
SENSIMED Triggerfish® signal increase when Goldman IOP increase is ≥ 3 mmHg following WDT

Study Overview

Brief Summary

The purpose of this study is to investigate the investigational device capacity to detect an intraocular pressure increase (IOP)induced by water intake.

Detailed Description

32 subjects will be enrolled in the investigation. Eligible subjects will receive one session of 4-6-hour continuous IOP monitoring with SENSIMED Triggerfish® following water drinking test (WDT). SENSIMED Triggerfish® will be installed randomly on right or left eyes and the IOP recording will be initiated as soon as the adaptation of the device on the subject's eye is satisfying. Sensor fitting in the eye will then be evaluated every 60 minutes, until no more spontaneous Sensor movement and rotation are observed. Then IOP will be measured on the contra lateral eye using Goldmann tonometer and the subjects will be asked to drink 1 liter of water within 5 minutes.

After the water drinking, IOP will be measured on the contra lateral eye 10 minutes after the beginning of the test then every 5 minutes until returned to normal. The IOP will be measured again every 20 minutes until 2 hours after the water drinking.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy volunteer without previous ocular medical history
  • 18 years or more at inclusion
  • Maximal weight: 100kg
  • BMI lower or equal to 30 kg/m2
  • Subjects having provided informed consent

Exclusion Criteria

  • Silicone allergy
  • Cardiovascular disease
  • Narrow or closed iridocorneal angle

Outcomes

Primary Outcomes

SENSIMED Triggerfish® signal increase when Goldman IOP increase is ≥ 3 mmHg following WDT

Time Frame: 30-45 min after WDT

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Sensimed AG
Sponsor Class
Industry

Study Sites (2)

Loading locations...

Similar Trials